SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
vividzxm
Lv1
40 积分
2021-12-09 加入
最近求助
最近应助
互助留言
重视卵巢癌的维持治疗
13天前
已完结
A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice
29天前
已完结
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
1个月前
已完结
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells
1个月前
已完结
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
2个月前
已完结
Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer
4个月前
已完结
Endometrial cancer
5个月前
已完结
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases
6个月前
已完结
Efficacy and Safety Comparison of Regorafenib and Fruquintinib in Metastatic Colorectal Cancer-An Observational Cohort Study in the Real World
10个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
1年前
已完结
Improved Ion Transport in Hydrogel-Based Nanofluidics for Osmotic Energy Conversion
2个月前
已采纳
标题错【积分已退回】
1年前
标题错误
1年前
无全文【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论